Welcome to our dedicated page for BKV SEC filings (Ticker: BKV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BKV Corporation (NYSE: BKV) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. BKV is an emerging growth company whose common stock is listed on the New York Stock Exchange, and its filings offer detailed information on its natural gas production business, midstream operations, power generation interests and carbon capture, utilization and sequestration (CCUS) activities.
Investors can review BKV’s current reports on Form 8-K, which describe material events such as underwritten public offerings of common stock, private offerings of senior notes due 2030, amendments to its reserve-based lending credit agreement, the authorization of a two-year share repurchase program and the entry into definitive agreements for acquisitions. These filings also summarize key terms of transactions, including the acquisition of Bedrock Production, LLC and the membership interest purchase agreement to increase BKV’s ownership in the BKV-BPP Power joint venture, which owns the Temple I and II combined cycle power plants in the ERCOT North Zone.
Form 8-K filings further identify BKV’s status as an emerging growth company, list its common stock registration under Section 12(b) of the Exchange Act and provide information on the use of proceeds from equity and debt offerings, such as funding acquisitions, repaying borrowings under the reserve-based lending credit agreement and general corporate purposes. Other disclosures include pro forma financial information reflecting completed acquisitions, unaudited consolidating financial information for BKV Upstream Midstream, and non-GAAP financial metrics such as Adjusted EBITDAX and Adjusted Free Cash Flow, with reconciliations to GAAP measures included in referenced exhibits.
On Stock Titan, these SEC filings are complemented by AI-powered summaries that help explain the significance of each document, highlight key terms and clarify how specific filings relate to BKV’s upstream, midstream, power generation and CCUS business lines. Users can quickly understand the implications of new 8-K filings, track changes to credit agreements and capital structure, and see how acquisitions and joint venture transactions affect BKV’s corporate profile.
BKV Corp (ticker: BKV) filed a Form 4 on 20 Jun 2025 disclosing an equity award to non-employee director Sunit S. Patel. On 19 Jun 2025 Mr. Patel received 5,761 restricted stock units (RSUs) at a grant price of $0 as part of the company’s standard non-employee director compensation program. Each RSU converts into one share of BKV common stock when vested.
The RSUs vest in full on the day prior to the 2026 annual shareholder meeting, providing roughly a one-year service and performance horizon. Following the grant, Mr. Patel’s total beneficial ownership increased to 55,761 shares, all held directly. No derivative securities or sales were reported, and the filing makes no reference to a Rule 10b5-1 trading plan.
From an investor perspective, the transaction is routine board compensation with immaterial dilution and no immediate cash impact on the company. It modestly aligns director incentives with shareholder value creation but does not signal a change in strategic outlook or financial condition. The filing satisfies Section 16 reporting requirements and carries no additional earnings data or operational disclosures.
BKV Corporation (ticker: BKV) filed a Form 4 disclosing an insider equity grant to director Charles C. Miller III. On 19 June 2025, Mr. Miller was awarded 5,761 restricted stock units (RSUs) under the company’s non-employee director compensation plan at a cost basis of $0.00. Each RSU converts into one share of common stock and will vest the day before BKV’s 2026 annual shareholder meeting.
Following this grant, the filing shows Miller’s updated beneficial ownership position at 5,761 shares held directly (the newly granted RSUs) and 87,500 shares held indirectly through the Miller/Allen Living Trust dated 8 January 2020.
No derivative securities were reported, and the transaction code "A" confirms the acquisition was an award rather than an open-market purchase. The filing was signed on 20 June 2025 by attorney-in-fact Kathleen Lenox.
For investors, this is a routine director equity grant designed to align board incentives with shareholder interests. The size of the award is modest relative to BKV’s total shares outstanding and does not, by itself, signal a material change in the company’s outlook or capital structure.